Attached files
| file | filename |
|---|---|
| 10-Q - Pathfinder Cell Therapy, Inc. | v200897_10q.htm |
| EX-10.1 - Pathfinder Cell Therapy, Inc. | v200897_ex10-1.htm |
| EX-31.1 - Pathfinder Cell Therapy, Inc. | v200897_ex31-1.htm |
EXIBIT
32.1: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL
FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002.*
In
connection with the accompanying Quarterly Report on Form 10-Q of SyntheMed,
Inc. for the quarter ended September 30, 2010, the undersigned hereby certifies
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief,
that:
|
|
(1)
|
such
Quarterly Report on Form 10-Q for the quarter ended September 30, 2010,
fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934;
and
|
|
|
(2)
|
the
information contained in such Quarterly Report on Form 10-Q for the
quarter ended September 30, 2010, fairly presents, in all material
respects, the financial condition and results of operations of SyntheMed,
Inc.
|
|
Dated: November 5,
2010
|
/s/ Robert P. Hickey
|
|
|
Name:
Robert P. Hickey
|
||
|
Title:
Chief Executive Officer and Chief Financial Officer
|
* A
signed original of this written statement required by Section 906, or other
document authenticating, acknowledging or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided by SyntheMed, Inc. and will be
retained by SyntheMed, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.